PAPER Cai M, Lee JH, Yang EJ
SEARCH RESULTS
18777 RESULTS
PAPER Bahji A, Meyyappan AC, Hawken ER
Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis.
Can J Psychiatry. 2020 Jun;65(6):365-376. Epub 2019 Dec 13 PubMed: 31835954PAPER Yiannopoulou KG, Anastasiou AI, Zachariou V, Pelidou SH
Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research.
Biomedicines. 2019 Dec 9;7(4) PubMed: 31835422PAPER Li SJ, Liu Q, He XB, Liu JP, Liu XL, Hu J, Tang ZP, Peng QY, Cui LJ, Zhang HN, Yang XL, Wang Q, Zhang ZJ
Pyrola incarnata demonstrates neuroprotective effects against β-amyloid-induced memory impairment in mice.
Bioorg Med Chem Lett. 2020 Jan 15;30(2):126858. Epub 2019 Dec 4 PubMed: 31836444PAPER Oboh G, Adebayo AA, Ademosun AO, Olowokere OG
Rutin restores neurobehavioral deficits via alterations in cadmium bioavailability in the brain of rats exposed to cadmium.
Neurotoxicology. 2020 Mar;77:12-19. Epub 2019 Dec 10 PubMed: 31836556PAPER Cochran JN, McKinley EC, Cochran M, Amaral MD, Moyers BA, Lasseigne BN, Gray DE, Lawlor JM, Prokop JW, Geier EG, Holt JM, Thompson ML, Newberry JS, Yokoyama JS, Worthey EA, Geldmacher DS, Love MN, Cooper GM, Myers RM, Roberson ED
Genome sequencing for early-onset or atypical dementia: high diagnostic yield and frequent observation of multiple contributory alleles.
Cold Spring Harb Mol Case Stud. 2019 Dec;5(6) Print 2019 Dec PubMed: 31836585Citalopram
THERAPEUTICS (RS)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile escitalopram Celexa Lexapro Cipralex Small Molecule Other Neurotransmitters In the first placebo-controlled trial of citalopram for behavioral disturbances in peop
Ariol Rama
Logos University CollegeTirana, Albania
Guanfacine
THERAPEUTICS N-amidino-2-(2,6dichlorophenyl) acetamide monohydrochloride Intuniv SPD503 Afken Estulic Tenex Small Molecule Other Neurotransmitters The idea that guanfacine might boost cognition in Alzheimer’s disease has been around for two decades, but not supported
PAPER Aathi M, Piramanayagam S
From EST to structure models for functional inference of APP, BACE1, PSEN1, PSEN2 genes.
Bioinformation. 2019;15(10):760-771. Epub 2019 Oct 31 PubMed: 31831959PAPER Singh B, Pandey S, Rumman M, Mahdi AA
Neuroprotective effects of Bacopa monnieri in Parkinson's disease model.
Metab Brain Dis. 2020 Mar;35(3):517-525. Epub 2019 Dec 13 PubMed: 31834548PAPER Ashton NJ, Ide M, Zetterberg H, Blennow K
Salivary Biomarkers for Alzheimer's Disease and Related Disorders.
Neurol Ther. 2019 Dec;8(Suppl 2):83-94. Epub 2019 Dec 12 PubMed: 31833026PAPER Peng G, Qiu J, Liu H, Zhou M, Huang S, Guo W, Lin Y, Chen X, Li Z, Li G, Zhang W, Zhang Y, Li X, Wu Z, Wei L, Yang X, Zhu X, Mo M, Xu P
Analysis of Cerebrospinal Fluid Soluble TREM2 and Polymorphisms in Sporadic Parkinson's Disease in a Chinese Population.
J Mol Neurosci. 2020 Feb;70(2):294-301. Epub 2019 Dec 12 PubMed: 31833018PAPER Li Y, Niu M, Zhao A, Kang W, Chen Z, Luo N, Zhou L, Zhu X, Lu L, Liu J
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson's disease.
J Neuroinflammation. 2019 Dec 12;16(1):263. PubMed: 31831012PAPER Liachko NF, Saxton AD, McMillan PJ, Strovas TJ, Keene CD, Bird TD, Kraemer BC
Genome wide analysis reveals heparan sulfate epimerase modulates TDP-43 proteinopathy.
PLoS Genet. 2019 Dec;15(12):e1008526. Epub 2019 Dec 13 PubMed: 31834878Current Filters
- Date Range : Oct 2019 to Oct 2020 x